US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist

4.350
-0.140-3.12%

Close Sep 17 16:00 ET

185.95MMarket Cap-8529P/E (TTM)

DiaMedica Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

10.16%-4.52M

-30.73%-6.65M

-62.70%-18.73M

-37.82%-3.81M

-103.18%-4.8M

-101.52%-5.03M

-30.89%-5.09M

6.05%-11.51M

1.36%-2.77M

22.49%-2.36M

Net income from continuing operations

-14.34%-5.12M

2.30%-5.15M

-41.72%-19.38M

-37.59%-5.16M

-46.16%-4.47M

-33.32%-4.48M

-50.29%-5.27M

-0.62%-13.68M

-15.56%-3.75M

11.33%-3.06M

Depreciation and amortization

42.86%10K

14.29%8K

20.00%30K

33.33%8K

14.29%8K

16.67%7K

4.17%25K

0.00%6K

16.67%7K

Other non cash items

11.76%19K

5.88%18K

9.38%70K

5.88%18K

12.50%18K

6.25%17K

13.33%17K

10.34%64K

13.33%17K

6.67%16K

Change In working capital

161.23%447K

-2,808.62%-1.69M

-84.10%93K

81.47%1.23M

-218.06%-353K

-267.82%-730K

93.00%-58K

226.90%585K

5,130.77%680K

346.27%299K

-Change in receivables

106.11%8K

-220.00%-30K

-697.92%-287K

-742.86%-59K

-1,038.46%-122K

-263.75%-131K

165.79%25K

-77.14%48K

73.08%-7K

114.77%13K

-Change in prepaid assets

-99.30%2K

-106.19%-1.47M

-196.30%-160K

775.00%700K

-240.19%-436K

12.99%287K

-1.72%-711K

56.10%-54K

-42.45%80K

1,827.78%311K

-Change in payables and accrued expense

149.32%437K

-130.41%-191K

-8.63%540K

-2.31%593K

920.00%205K

-977.23%-886K

782.61%628K

207.85%591K

707.00%607K

-114.45%-25K

Cash from discontinued investing activities

Operating cash flow

10.16%-4.52M

-30.73%-6.65M

-62.70%-18.73M

-37.82%-3.81M

-103.18%-4.8M

-101.52%-5.03M

-30.89%-5.09M

6.05%-11.51M

1.36%-2.77M

22.49%-2.36M

Investing cash flow

Cash flow from continuing investing activities

116.84%4.74M

67.72%4.21M

-258.60%-18.3M

29.64%6.12M

-42.28%1.2M

-1,212.66%-28.13M

13.32%2.51M

156.18%11.54M

154.37%4.72M

116.15%2.07M

Net PPE purchase and sale

--0

-28.57%-9K

70.37%-24K

90.63%-3K

76.74%-10K

33.33%-4K

---7K

-305.00%-81K

-357.14%-32K

-2,050.00%-43K

Net investment purchase and sale

116.84%4.74M

67.61%4.22M

-257.29%-18.28M

28.83%6.13M

-42.98%1.21M

-1,209.87%-28.12M

13.64%2.52M

156.63%11.62M

154.78%4.76M

116.49%2.12M

Cash from discontinued investing activities

Investing cash flow

116.84%4.74M

67.72%4.21M

-258.60%-18.3M

29.64%6.12M

-42.28%1.2M

-1,212.66%-28.13M

13.32%2.51M

156.18%11.54M

154.37%4.72M

116.15%2.07M

Financing cash flow

Cash flow from continuing financing activities

-68.11%11.75M

0.00%-1K

614,133.33%36.84M

0.00%-1K

-200.00%-6K

1,842,600.00%36.85M

0.00%-1K

-100.02%-6K

94.74%-1K

-100.01%-2K

Net issuance payments of debt

0.00%-2K

0.00%-1K

0.00%-6K

0.00%-1K

0.00%-2K

0.00%-1K

0.00%-6K

0.00%-1K

0.00%-2K

Net common stock issuance

----

--36.85M

--0

---4K

----

--0

Cash from discontinued financing activities

Financing cash flow

-68.11%11.75M

0.00%-1K

614,133.33%36.84M

0.00%-1K

-200.00%-6K

1,842,600.00%36.85M

0.00%-1K

-100.02%-6K

94.74%-1K

-100.01%-2K

Net cash flow

Beginning cash position

-2.33%2.1M

-3.91%4.54M

0.45%4.73M

-19.45%2.23M

90.69%5.84M

-29.19%2.15M

0.45%4.73M

-36.47%4.71M

-82.92%2.77M

37.43%3.06M

Current changes in cash

224.19%11.97M

5.23%-2.45M

-980.95%-185K

18.09%2.31M

-1,139.52%-3.61M

12,206.67%3.69M

-54.09%-2.58M

100.78%21K

117.00%1.96M

-102.08%-291K

End cash Position

140.90%14.07M

-2.33%2.1M

-3.91%4.54M

-19.45%2.23M

90.69%5.84M

-29.19%2.15M

0.45%4.73M

-82.92%2.77M

Free cash flow

10.23%-4.52M

-30.73%-6.66M

-61.77%-18.75M

-36.35%-3.82M

-99.96%-4.81M

-101.20%-5.03M

-31.07%-5.1M

5.56%-11.59M

0.46%-2.8M

21.13%-2.4M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	10.16%-4.52M	-30.73%-6.65M	-62.70%-18.73M	-37.82%-3.81M	-103.18%-4.8M	-101.52%-5.03M	-30.89%-5.09M	6.05%-11.51M	1.36%-2.77M	22.49%-2.36M
Net income from continuing operations	-14.34%-5.12M	2.30%-5.15M	-41.72%-19.38M	-37.59%-5.16M	-46.16%-4.47M	-33.32%-4.48M	-50.29%-5.27M	-0.62%-13.68M	-15.56%-3.75M	11.33%-3.06M
Depreciation and amortization	42.86%10K	14.29%8K	20.00%30K	33.33%8K	14.29%8K	16.67%7K	16.67%7K	4.17%25K	0.00%6K	16.67%7K
Other non cash items	11.76%19K	5.88%18K	9.38%70K	5.88%18K	12.50%18K	6.25%17K	13.33%17K	10.34%64K	13.33%17K	6.67%16K
Change In working capital	161.23%447K	-2,808.62%-1.69M	-84.10%93K	81.47%1.23M	-218.06%-353K	-267.82%-730K	93.00%-58K	226.90%585K	5,130.77%680K	346.27%299K
-Change in receivables	106.11%8K	-220.00%-30K	-697.92%-287K	-742.86%-59K	-1,038.46%-122K	-263.75%-131K	165.79%25K	-77.14%48K	73.08%-7K	114.77%13K
-Change in prepaid assets	-99.30%2K	-106.19%-1.47M	-196.30%-160K	775.00%700K	-240.19%-436K	12.99%287K	-1.72%-711K	56.10%-54K	-42.45%80K	1,827.78%311K
-Change in payables and accrued expense	149.32%437K	-130.41%-191K	-8.63%540K	-2.31%593K	920.00%205K	-977.23%-886K	782.61%628K	207.85%591K	707.00%607K	-114.45%-25K
Cash from discontinued investing activities
Operating cash flow	10.16%-4.52M	-30.73%-6.65M	-62.70%-18.73M	-37.82%-3.81M	-103.18%-4.8M	-101.52%-5.03M	-30.89%-5.09M	6.05%-11.51M	1.36%-2.77M	22.49%-2.36M
Investing cash flow
Cash flow from continuing investing activities	116.84%4.74M	67.72%4.21M	-258.60%-18.3M	29.64%6.12M	-42.28%1.2M	-1,212.66%-28.13M	13.32%2.51M	156.18%11.54M	154.37%4.72M	116.15%2.07M
Net PPE purchase and sale	--0	-28.57%-9K	70.37%-24K	90.63%-3K	76.74%-10K	33.33%-4K	---7K	-305.00%-81K	-357.14%-32K	-2,050.00%-43K
Net investment purchase and sale	116.84%4.74M	67.61%4.22M	-257.29%-18.28M	28.83%6.13M	-42.98%1.21M	-1,209.87%-28.12M	13.64%2.52M	156.63%11.62M	154.78%4.76M	116.49%2.12M
Cash from discontinued investing activities
Investing cash flow	116.84%4.74M	67.72%4.21M	-258.60%-18.3M	29.64%6.12M	-42.28%1.2M	-1,212.66%-28.13M	13.32%2.51M	156.18%11.54M	154.37%4.72M	116.15%2.07M
Financing cash flow
Cash flow from continuing financing activities	-68.11%11.75M	0.00%-1K	614,133.33%36.84M	0.00%-1K	-200.00%-6K	1,842,600.00%36.85M	0.00%-1K	-100.02%-6K	94.74%-1K	-100.01%-2K
Net issuance payments of debt	0.00%-2K	0.00%-1K	0.00%-6K	0.00%-1K	0.00%-2K	0.00%-2K	0.00%-1K	0.00%-6K	0.00%-1K	0.00%-2K
Net common stock issuance	----	----	--36.85M	--0	---4K	----	----	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	-68.11%11.75M	0.00%-1K	614,133.33%36.84M	0.00%-1K	-200.00%-6K	1,842,600.00%36.85M	0.00%-1K	-100.02%-6K	94.74%-1K	-100.01%-2K
Net cash flow
Beginning cash position	-2.33%2.1M	-3.91%4.54M	0.45%4.73M	-19.45%2.23M	90.69%5.84M	-29.19%2.15M	0.45%4.73M	-36.47%4.71M	-82.92%2.77M	37.43%3.06M
Current changes in cash	224.19%11.97M	5.23%-2.45M	-980.95%-185K	18.09%2.31M	-1,139.52%-3.61M	12,206.67%3.69M	-54.09%-2.58M	100.78%21K	117.00%1.96M	-102.08%-291K
End cash Position	140.90%14.07M	-2.33%2.1M	-3.91%4.54M	-3.91%4.54M	-19.45%2.23M	90.69%5.84M	-29.19%2.15M	0.45%4.73M	0.45%4.73M	-82.92%2.77M
Free cash flow	10.23%-4.52M	-30.73%-6.66M	-61.77%-18.75M	-36.35%-3.82M	-99.96%-4.81M	-101.20%-5.03M	-31.07%-5.1M	5.56%-11.59M	0.46%-2.8M	21.13%-2.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data